Huage Zhong

453 total citations
22 papers, 202 citations indexed

About

Huage Zhong is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Huage Zhong has authored 22 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Huage Zhong's work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huage Zhong is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huage Zhong collaborates with scholars based in China and United States. Huage Zhong's co-authors include Tao Luo, Fengna Xi, Yan Liu, Miao Chen, Weizhong Tang, Yijun Song, Qingli Dou, Xin Yu, Hao Wen and Y. Wang and has published in prestigious journals such as Radiology, International Journal of Radiation Oncology*Biology*Physics and RSC Advances.

In The Last Decade

Huage Zhong

21 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huage Zhong China 8 76 50 48 35 32 22 202
Ruidan Li China 10 70 0.9× 60 1.2× 25 0.5× 31 0.9× 26 0.8× 44 278
Ingo Ganzleben Germany 7 74 1.0× 16 0.3× 27 0.6× 38 1.1× 25 0.8× 15 270
Lixing Chen China 12 115 1.5× 38 0.8× 26 0.5× 14 0.4× 32 1.0× 27 309
Jie Zeng China 9 78 1.0× 54 1.1× 22 0.5× 16 0.5× 78 2.4× 28 299
Qunfang Xie China 7 171 2.3× 39 0.8× 23 0.5× 63 1.8× 87 2.7× 11 426
Wen‐Jiun Lin Taiwan 10 79 1.0× 44 0.9× 30 0.6× 28 0.8× 45 1.4× 21 450
Luciano Carlucci Italy 6 65 0.9× 40 0.8× 46 1.0× 7 0.2× 20 0.6× 12 233
Nidhi Verma India 12 118 1.6× 52 1.0× 18 0.4× 48 1.4× 102 3.2× 55 404
Huiting Xu China 11 144 1.9× 25 0.5× 35 0.7× 20 0.6× 72 2.3× 30 389
Eli Mohapatra India 8 80 1.1× 24 0.5× 37 0.8× 23 0.7× 74 2.3× 48 267

Countries citing papers authored by Huage Zhong

Since Specialization
Citations

This map shows the geographic impact of Huage Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huage Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huage Zhong more than expected).

Fields of papers citing papers by Huage Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huage Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huage Zhong. The network helps show where Huage Zhong may publish in the future.

Co-authorship network of co-authors of Huage Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Huage Zhong. A scholar is included among the top collaborators of Huage Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huage Zhong. Huage Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Shuo, et al.. (2025). FAM64A regulates the malignant phenotype and tumor microenvironment of non-small cell lung cancer by activating the JAK/STAT3/PDL1 axis. Journal of Molecular Histology. 56(2). 95–95. 1 indexed citations
2.
Li, Xiang, et al.. (2025). Exploring the Role of Epithelial–Mesenchymal Transition During Colorectal Cancer Peritoneal Metastasis: Update on Their Mechanisms. Journal of Biochemical and Molecular Toxicology. 39(2). e70166–e70166.
3.
Chen, Tianyu, Xiang Li, Min Lin, et al.. (2025). SREBP2 as a central player in cancer progression: potential for targeted therapeutics. Frontiers in Pharmacology. 16. 1535691–1535691. 1 indexed citations
4.
Huang, Jiahao, et al.. (2024). Integrin α6 and integrin β4 in exosomes promote lung metastasis of colorectal cancer. Journal of Cancer Research and Therapeutics. 20(7). 2082–2093. 2 indexed citations
5.
Li, Jianming, Guangjian Liu, Xiaoyan Xie, et al.. (2024). Thermal ablation with and without adjuvant systemic therapy: a nationwide multicenter observational cohort study of solitary colorectal liver metastases. International Journal of Surgery. 110(7). 4240–4248. 3 indexed citations
6.
Li, Jianming, Xiaoyan Xie, Dezhi Zhang, et al.. (2023). Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases. Radiology. 308(2). e223135–e223135. 6 indexed citations
7.
Li, Jianming, Jie Yu, Guangjian Liu, et al.. (2022). Up-Front Versus Delayed Thermal Ablation for Colorectal Liver Oligometastases: A Multicenter Retrospective Study Using Propensity Score Matching. American Journal of Roentgenology. 220(6). 885–899. 1 indexed citations
8.
Zhong, Huage, et al.. (2022). MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer. World Journal of Surgical Oncology. 20(1). 257–257. 5 indexed citations
9.
Zhong, Huage, Zheng Wang, Xiaoxia Wei, et al.. (2022). Prognostic and immunological role of SERPINH1 in pan-cancer. Frontiers in Genetics. 13. 900495–900495. 5 indexed citations
10.
Xu, Yansong, Gang Liu, Chang Zhao, et al.. (2021). Prognostic Value of Combined Preoperative Carcinoembryonic Antigen and Prognostic Nutritional Index in Patients With Stage II–III Colon Cancer. Frontiers in Surgery. 8. 667154–667154. 9 indexed citations
11.
Xu, Yansong, et al.. (2021). Preoperative Predictors of Lymph Node Metastasis in Colon Cancer. Frontiers in Oncology. 11. 667477–667477. 7 indexed citations
12.
Xu, Yansong, et al.. (2021). Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma. Frontiers in Molecular Biosciences. 8. 673918–673918. 2 indexed citations
13.
Liu, Jungang, Haizhou Liu, Lan Jin, et al.. (2021). An Applicable Inflammation-Joined and Nutrition-Related Prognostic Indicator in Patients With Colorectal Cancer. Frontiers in Oncology. 11. 644670–644670. 6 indexed citations
14.
Chen, Yi, Yansong Xu, Huage Zhong, et al.. (2021). Extracellular vesicles in Inter-Kingdom communication in gastrointestinal cancer.. American Journal of Cancer Research. 11(4). 1087–1103. 15 indexed citations
15.
16.
Zhong, Huage, et al.. (2020). ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. BioMed Research International. 2020(1). 3575038–3575038. 9 indexed citations
17.
Xu, Yansong, et al.. (2020). Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer. BioMed Research International. 2020(1). 8812974–8812974. 6 indexed citations
18.
Zhong, Huage, Jie Chen, Miao Chen, et al.. (2020). Electrochemical immunosensor with surface-confined probe for sensitive and reagentless detection of breast cancer biomarker. RSC Advances. 10(38). 22291–22296. 16 indexed citations
19.
Huang, Jiahao, Yang Zhao, Lin Liao, et al.. (2019). Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer. BioMed Research International. 2019. 1–7. 13 indexed citations
20.
Yu, Xin, Y. Wang, Huage Zhong, et al.. (2014). Diagnostic Value of Serum Procalcitonin in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation Proceedings. 46(1). 26–32. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026